BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4662918)

  • 1. [Cytostatic treatment of plasmacytoma].
    Günther I; Gladitz G
    Z Gesamte Inn Med; 1972 Nov; 27(21):933-7. PubMed ID: 4662918
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of chemotherapy on the survival of patients with generalized plasmacytoma and various hazards of its toxicity].
    Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J; Oravská D; Pokorná G; Mayer J
    Vnitr Lek; 1979 May; 25(5):425-35. PubMed ID: 452427
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of plasmacytoma therapy].
    Fateh-Moghadam A; Sandel P; Ehrhart H; Knedel M
    Hamatol Bluttransfus; 1976; 18():395-400. PubMed ID: 964715
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interim results of the combination of M2 polychemotherapy with calcitonin and synthetic anabolic agents in the treatment of plasmacytoma].
    Fremiotti A; Castellani R; Barbatano L; Salerno L; Bartolini M
    Recenti Prog Med; 1979 Apr; 66(4):418-26. PubMed ID: 113855
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute new proliferation inparaproteinemic hemoblastoses during long-term treatment with cytostatic agents].
    Klemm D; Merker H; Westerhausen M
    Dtsch Med Wochenschr; 1968 Oct; 93(43):2063-4 passim. PubMed ID: 4971817
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of therapy on the longevity of patients with plasmacytoma in relation to disease stage and intensity of therapy].
    Fröhlich C; Köhle U; Rietsch R
    Med Welt; 1971 Apr; 17():713-7. PubMed ID: 5555293
    [No Abstract]   [Full Text] [Related]  

  • 7. [Duration of disease and survival time in plasmacytoma].
    Rautenstrauch H
    Z Gesamte Inn Med; 1970 Dec; 25(23):1071-4. PubMed ID: 5512749
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience in the diagnosis and therapy of plasmacytoma (author's transl)].
    Kahler OH
    Wien Med Wochenschr; 1979 Feb; 129(4):101-6. PubMed ID: 425546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse intravenous cyclophosphamide for treatment of autoimmune blistering disease. Is there an advantage over oral routes?
    Werth VP
    Arch Dermatol; 1997 Feb; 133(2):229-30. PubMed ID: 9041839
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the treatment of chronic polyarthritis with cytostatic drugs. II. Oral application of Trenimon. Clinical and serological studies].
    Prohaska E; Chlud K; Pfaller C
    Z Rheumaforsch; 1968 Feb; 27(1):39-47. PubMed ID: 5715915
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of plasmacytoma].
    Fateh-Moghadam A
    Munch Med Wochenschr; 1973 May; 115(18):861-4. PubMed ID: 4800218
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative immunoglobulin determination in myeloma during cystostatic therapy].
    Klein WW
    Wien Med Wochenschr; 1972 Apr; 122(14):191-3. PubMed ID: 5014037
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the evaluation of the cytostatic therapeutic action in paraproteinemias].
    Wetter O
    Verh Dtsch Ges Inn Med; 1967; 73():349-52. PubMed ID: 4173591
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of paraproteinemic hemoblastoses].
    Fereberger W
    Acta Med Austriaca; 1982; 9(4):151-7. PubMed ID: 6814158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.
    Schabel FM
    Cancer Res; 1969 Dec; 29(12):2384-9. PubMed ID: 5369685
    [No Abstract]   [Full Text] [Related]  

  • 16. Low dose cyclophosphamide treatment on the myeloma.
    Isobe T; Horimatsu T; Matsumoto J; Kishihara M; Fujita T
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):678-83. PubMed ID: 506650
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of cytostatic therapy of malignant hemoblastoses].
    Stacher A
    Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
    [No Abstract]   [Full Text] [Related]  

  • 18. [Various problems in the diagnosis and therapy of plasmacytoma in geriatrics].
    Biró I
    Z Alternsforsch; 1971; 23(4):377-84. PubMed ID: 5123825
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization].
    Moldenhauer H; Rose H; Saul G; Wolf G; Kehrberg G
    Radiobiol Radiother (Berl); 1984; 25(2):289-95. PubMed ID: 6234615
    [No Abstract]   [Full Text] [Related]  

  • 20. [New formation of malignant tumors during cytostatic therapy. Case report].
    Renner K
    Strahlentherapie; 1971 Sep; 142(3):308-11. PubMed ID: 5118499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.